207 related articles for article (PubMed ID: 36246555)
1. Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma.
Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics technologies and molecular biomarkers in brain tumor-related epilepsy.
Du Y; Li R; Fu D; Zhang B; Cui A; Shao Y; Lai Z; Chen R; Chen B; Wang Z; Zhang W; Chu L
CNS Neurosci Ther; 2024 Apr; 30(4):e14717. PubMed ID: 38641945
[TBL] [Abstract][Full Text] [Related]
3. Correlation of preoperative seizures with a wide range of tumor molecular markers in gliomas: An analysis of 442 glioma patients from China.
Shen S; Bai Y; Zhang B; Liu T; Yu X; Feng S
Epilepsy Res; 2020 Oct; 166():106430. PubMed ID: 32712511
[TBL] [Abstract][Full Text] [Related]
4. IDH1 and IDH2 mutations in postoperative diffuse glioma-associated epilepsy.
Neal A; Kwan P; O'Brien TJ; Buckland ME; Gonzales M; Morokoff A
Epilepsy Behav; 2018 Jan; 78():30-36. PubMed ID: 29172136
[TBL] [Abstract][Full Text] [Related]
5. An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy.
Yang Y; Mao Q; Wang X; Liu Y; Mao Y; Zhou Q; Luo J
J Clin Neurosci; 2016 Sep; 31():56-62. PubMed ID: 27406953
[TBL] [Abstract][Full Text] [Related]
6. Correlation of preoperative seizures with clinicopathological factors and prognosis in anaplastic gliomas: a report of 198 patients from China.
Yang P; You G; Zhang W; Wang Y; Wang Y; Yao K; Jiang T
Seizure; 2014 Nov; 23(10):844-51. PubMed ID: 25153654
[TBL] [Abstract][Full Text] [Related]
7. IDH1 mutation predicts seizure occurrence and prognosis in lower-grade glioma adults.
Tang T; Wang Y; Dai Y; Liu Q; Fan X; Cheng Y; Tang J; Xiao X; Shan Y; Wei P; Zhao G
Pathol Res Pract; 2024 Feb; 254():155165. PubMed ID: 38286053
[TBL] [Abstract][Full Text] [Related]
8. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
9. IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis.
Li Y; Shan X; Wu Z; Wang Y; Ling M; Fan X
Seizure; 2018 Feb; 55():76-82. PubMed ID: 29414139
[TBL] [Abstract][Full Text] [Related]
10. Epilepsy in patients with gliomas: incidence and control of seizures.
Iuchi T; Hasegawa Y; Kawasaki K; Sakaida T
J Clin Neurosci; 2015 Jan; 22(1):87-91. PubMed ID: 25192590
[TBL] [Abstract][Full Text] [Related]
11. IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas.
Duan WC; Wang L; Li K; Wang WW; Zhan YB; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZY
Medicine (Baltimore); 2018 Dec; 97(50):e13675. PubMed ID: 30558073
[TBL] [Abstract][Full Text] [Related]
12. Brain tumor related-epilepsy.
Goldstein ED; Feyissa AM
Neurol Neurochir Pol; 2018 Aug; 52(4):436-447. PubMed ID: 30122210
[TBL] [Abstract][Full Text] [Related]
13. High expression of cystine-glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma.
Sørensen MF; Heimisdóttir SB; Sørensen MD; Mellegaard CS; Wohlleben H; Kristensen BW; Beier CP
J Neurooncol; 2018 May; 138(1):49-53. PubMed ID: 29404978
[TBL] [Abstract][Full Text] [Related]
14. The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas.
Liang R; Fan Y; Wang X; Mao Q; Liu Y
ScientificWorldJournal; 2013; 2013():403942. PubMed ID: 24324372
[TBL] [Abstract][Full Text] [Related]
15. Potential influence of IDH1 mutation and MGMT gene promoter methylation on glioma-related preoperative seizures and postoperative seizure control.
Feyissa AM; Worrell GA; Tatum WO; Chaichana KL; Jentoft ME; Guerrero Cazares H; Ertekin-Taner N; Rosenfeld SS; ReFaey K; Quinones-Hinojosa A
Seizure; 2019 Jul; 69():283-289. PubMed ID: 31141785
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control.
Yuan Y; Xiang W; Yanhui L; Ruofei L; Shuang L; Yingjun F; Qiao Z; Yanwu Y; Qing M
Seizure; 2013 Dec; 22(10):877-81. PubMed ID: 23992787
[TBL] [Abstract][Full Text] [Related]
17. Eslicarbazepine in patients with brain tumor-related epilepsy: a single-center experience.
Zoccarato M; Basile AM; Padovan M; Caccese M; Zagonel V; Lombardi G
Int J Neurosci; 2021 Sep; 131(9):879-884. PubMed ID: 32316814
[TBL] [Abstract][Full Text] [Related]
18. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
19. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
Maschio M; Zarabla A; Maialetti A; Sperati F; Dinapoli L; Dispenza S; Petreri G; Cantelmi T
Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
[TBL] [Abstract][Full Text] [Related]
20. Perampanel in patients with brain tumor-related epilepsy in real-life clinical practice: a retrospective analysis.
Maschio M; Pauletto G; Zarabla A; Maialetti A; Ius T; Villani V; Fabi A; Koudriavtseva T; Giannarelli D
Int J Neurosci; 2019 Jun; 129(6):593-597. PubMed ID: 30507318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]